The company held 2016 annual board of directors, board of supervisors
Release time:
2020-08-14
Company Held 2016 Board of Directors and Board of Supervisors
to Review and Pass the Board's Work Report and Other Proposals and Reports
News 4# November 15 , the 11 Meeting of the 9th Board of Directors of the Group Company was held in Jianfeng Building, deliberated and passed 2016 Board of Directors Work Report, 2016 General Manager Work Report and other 14 proposals and reports. The
meeting was presided over by Jiang Xiaomeng, chairman of the group company. Yu Jianhong, general manager, made an annual work report on behalf of the management team, comprehensively summarizing and reviewing the company's 2016 work.
In 2016 , the company focused on the general policy of "innovation, integration, improvement, and development", actively sought new opportunities for development, made new breakthroughs in cooperative innovation, carried out in-depth management integration, continuously improved management levels, and strengthened marketing Management and market expansion have achieved steady growth in product sales, technological innovation and technological transformation have achieved obvious results, and corporate image and influence have been effectively improved. The company realized operating income of 23.79 .2 billion yuan for the whole year, up 5.34% year on year. Net profit attributable to owners of the parent company 28522.95 yuan, up 41.98% year on year, the highest level in history. By the end of 2016 , the company's total assets were 39.95 .2 billion yuan, up 10% year on year. Net assets were 25.52 .6 billion yuan, up 9.82 year on year.
2016 , thanks to the national strategy of "the belt and road initiative", the national cement production increased by 2.3% year-on-year, driven by the recovery of infrastructure investment and real estate investment. The growth of total demand, the development and construction of the southwest region and the implementation of a series of structural reform measures on the supply side of the cement industry, including peak production, industry self-discipline and market integration, cement prices rebounded after bottoming out in the first half of 2016 , and the cement industry in some areas improved. The company's cement business sector seized the opportunity of supply-side reform, actively advocated industry self-discipline, and worked closely around the cost-leading strategy. Daye Peak actively participated in large-scale project bidding while increasing the expansion of the civil market for bagged cement, striving to maintain the gross profit level of tons of cement and ensuring the balance of production and sales in the off-season market. Yunnan Peak strives to enhance the brand status of Peak Cement and advocates self-discipline in the cement industry in southwest Yunnan, actively develop key projects, continue to expand market share, and significantly improve economic efficiency.
Peak Pharmaceutical strives to seek new projects and make new breakthroughs according to strategic planning. In terms of business development, Jianfeng Pharmaceutical has introduced advanced German technology and established a Sino-German joint venture Zhejiang Jindal Baby Drug Co., Ltd. to build a platform specializing in the research and development, production and operation of infant drugs. After more than half a year of research and negotiation, it successfully reached an agreement with Beihui Biology's major shareholders to take a stake in Beihui Biology by way of capital increase and equity transfer. In terms of equity investment, the company also completed the capital increase of Peak Pharmaceuticals and Tianshili Group. In terms of product sales, efforts have been made to realize the entry of peak pharmaceutical products into various catalogues. Jinhua Pharmaceutical Company has obtained the qualification of main distribution in Yiwu primary hospitals. Peak pharmacy has added 4 chain stores and 4 designated medical insurance pharmacies, realizing sales growth. In terms of technological innovation, the research and development project of Jianfeng Pharmaceutical's new anti-tumor drug DPT (deoxypodophyllotoxin) is progressing smoothly, and it has obtained clinical trial approval documents issued by CFDA and obtained a number of related invention patents.
peak health food extraction workshop passed GMP certification, extraction workshop passed Kosher (clean food), halal (halal) certification, and passed ISO9001 , ISO22000 system on-site audit; Complete the drug production record of Ginkgo biloba extract and the establishment of GMP management system, complete the certification of SC for 5 unit foods such as jelly, flavored tea, plant beverages, etc. Tianjin Jianfeng Natural Products Company has strengthened the development of the domestic market while continuing to expand the international market, realizing the simultaneous growth of international and domestic market sales. Peak cable through the product system, Ter and other certification supervision and inspection, large logarithmic cable successfully entered the Hangzhou G20 project. At the same time, the company takes budget management and benchmarking management as the guidance, fine management and PDCA
also deliberated and approved the "plan on profit distribution for 2016
2016 , based on 2016 year-end share capital ,344,083, 828 shares, and distribute cash dividend 2.5 yuan (including tax) for every 10 shares, the total amount of cash dividends distributed to all shareholders registered on the date of record is 86,020,957.00 yuan (including tax), and 2016 will not be converted into share capital. The distribution plan still needs to be approved by the general meeting of shareholders. If it is implemented, the cash dividend accumulated by the company to shareholders in the last three years will reach 23397.70 .14 million yuan. On the same day, 115 , the company also held the 119 meeting of the 10th 118 of the 8th board of supervisors, deliberated and passed the 123 proposals and reports of the 5th board of supervisors of the company 2016 and the proposal on adding supervisors. (Zhou Hengbin)
More information
In the eastern corner of the production area of Jianfeng Health Technology Company, there is a very inconspicuous building. From below, only a few pipes of uneven thickness can be seen on the top and the slogan "Focus on Environmental Protection and Promote Sustainable Development" with red letters on the yellow background on the stainless steel guardrail. Walking up, you can only see several closed pools and a small room with stacks of documents, test tubes, glass bottles and other testing tools on the table. This is the peak and healthy sewage treatment station. The production sewage of the whole factory area is concentrated here. After adjustment (PH adjustment), pre-acidification, anaerobic, anoxic, aerobic (aeration), precipitation and other links, it is discharged into the pipe network after reaching the special discharge standard. Yin Zhiwu, executive deputy general manager of Jianfeng Health, said that because the sewage treatment station in Wucheng District has not yet been built, Jianfeng Health has not yet been able to achieve pipe discharge, and the relevant national laws have strict requirements on the discharge of water pollutants from the extraction pharmaceutical industry. Sewage discharge must reach a special discharge limit, that is, chemical oxygen demand (COD) must be less than 50 mg/L. Enterprise development and environmental protection are both the concept of peak health since its establishment. In March this year, on the basis of the original environmental protection facilities, Jianfeng Health carried out technical renovation of waste gas collection and treatment facilities, and at the same time installed a sealing cover on the sewage treatment station to realize the closed collection of waste gas. Since the trial operation of this facility in mid-May, the overall effect has been obvious. The original treatment tank would emit an unpleasant smell during work, but now the smell has been significantly reduced. Compared with the young enterprise of peak health, the relatively "older" peak pharmaceutical has more experience in sewage treatment and environmental protection. Akihama
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-30
Jianfeng Pharmaceutical Won Advanced Collective of Municipal Red Cross Humanitarian Promotion Award
On April 24, the Red Cross Society of Jinhua issued a circular commending the advanced units and individuals of the 2016 Red Cross Humanitarian Promotion Award. Peak Pharmaceutical Company won the Red Cross Humanitarian Promotion Award for Advanced Collective. The Red Cross is a social relief organization engaged in humanitarian work, with the purpose of carrying forward the spirit of humanity, fraternity and dedication, protecting human life and health, and promoting the cause of peace and progress of mankind. As a socially responsible enterprise, Jianfeng Pharmaceutical has always attached importance to public welfare and charity work, vigorously promoted the spirit of the Red Cross, and vigorously supported the work of the Red Cross with practical actions. In September 2016, at the theme publicity activity of "World First Aid Day" and the opening ceremony of the municipal Red Cross emergency rescue station (point), Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, donated 6 AEDs known as "life-saving artifact" to the Red Cross on behalf of Jianfeng Pharmaceutical, it is equipped with six Red Cross emergency rescue service stations (points), namely, Jinhua high-speed railway station, sports center, cultural center, Shuanglong scenic spot, Siping village scenic spot and Suoyuan village scenic spot. The configuration of AED equipment has played a very good role in improving the emergency rescue capacity of Jinhua's key locations, and has been affirmed by the Red Cross and related units. (Spike Pharmaceuticals)
2020
07-31
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-31